Jiangxi Sanxin Medtec Co Ltd

Jiangxi Sanxin Medtec Co Ltd

300453 · SHE · Healthcare / Medical Instruments & Supplies

9.44CNY-0.02 (-0.21%)

Price History

Full chart

Market Stats

Previous Close9.46
Open9.50
Day Range9.28 – 9.50
52-Week Range8.33 – 10.44
Volume5.32M
Market Cap4.72B
P/E (TTM)16.76
Forward P/E0.00
EPS0.54
Dividend Yield3.32%
Beta0.10
50-Day Avg9.44
200-Day Avg9.50

About

Jiangxi Sanxin Medtec Co.,Ltd. engages in the research and development, manufacture, sale, and service of medical devices. It offers infusion and cardiothoracic surgery products and blood purification products, such as central concentrate delivery systems, disposable biological protein glue dispensers, disposable blood dialyzers, hemodialysis filters, hemodialysis concentrates and powders, continuous blood purification pipelines and accessories, dialysis fluid filters, disposable dialysis indwelling needles, dialysis filtration machines, hemodialysis water production systems, centralized liquid supply systems, disposable hollow fiber dialyzers, hemodialysis extracorporeal circulation tubing, hemodialysis tubing, machine blood collection devices, blood purification and fluid replacement pipelines, and central venous catheter kits. It also provides prefilled catheter flushing devices, heparin caps, sterile needles, disposable filtration infusion sets, disposable light-shielded precision filtration infusion sets, blood transfusion devices, infusion disinfection connectors, Y-shaped indwelling needles, closed vein indwelling needles, pneumatic needle-free injectors, insulin syringes, injection needles, dispensing syringes, disposable sterile syringes, fixed-dose vaccine injectors, light-proof pressure extension tubes, positive pressure intravenous catheters, indwelling needles, and retractable self-destruct syringes. In addition, the company offers right heart suction heads, cardiopulmonary bypass connectors, blood clot filters, cold pump infusion devices, artificial heart-lung extracorporeal circulation tubing packages, and disposable blood storage and filtration devices. Further, it provides disposable balloon inflation pressure pumps, vascular sheath sets, and PTA high-pressure balloon dilation catheters, as well as medical needle-free injectors. Jiangxi Sanxin Medtec Co.,Ltd. was founded in 1997 and is headquartered in Nanchang, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Zhiping Mao
  • Employees2.30K
  • HeadquartersNo. 999 Fushan Avenue, Nanchang, China, 330200, China
  • Websitehttps://www.sanxin-med.com

Leadership

  • Mr. Zhiping MaoGM & Non-Independent Director · b. 1974
  • Mr. Ming LiuVP, Acting Financial Director, Board Secretary & Non-Independent Director · b. 1989
  • Ms. Ling PengVP & Non-independent Director · b. 1982
  • Ms. Ganying WangVice President · b. 1980
  • Ms. Lingli LengVice President · b. 1983
  • Mr. Bing Rong LiuVice President · b. 1984
  • Ms. Nan Mei ShuAccounting Officer

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue220.40M280.44M304.74M322.20M311.85M317.77M403.87M531.30M721.67M940.39M1.16B1.34B1.30B1.50B1.64B
Growth (%)-+27.24%+8.66%+5.73%-3.21%+1.90%+27.09%+31.55%+35.83%+30.31%+23.81%+14.75%-2.69%+15.41%+9.31%
Cost of Revenue149.47M178.84M199.31M216.80M203.43M211.67M279.14M372.71M474.05M636.23M763.96M886.52M847.27M972.05M1.05B
Gross Profit70.93M101.60M105.43M105.40M108.42M106.11M124.73M158.59M247.62M304.15M400.33M449.49M452.79M528.39M590.86M
Gross Margin32.18%36.23%34.60%32.71%34.77%33.39%30.88%29.85%34.31%32.34%34.38%33.64%34.83%35.22%36.03%
Operating Expense32.66M51.17M51.91M53.33M56.13M62.59M75.68M110.61M170.10M148.98M205.29M219.47M195.15M249.54M267.64M
Operating Income38.27M50.44M53.52M52.07M52.29M43.52M49.05M47.98M77.52M155.17M195.04M230.02M257.64M278.85M323.23M
Operating Margin17.36%17.98%17.56%16.16%16.77%13.69%12.14%9.03%10.74%16.50%16.75%17.22%19.82%18.58%19.71%
EBITDA48.85M67.45M71.43M73.03M75.61M57.95M70.34M78.99M117.90M204.95M253.00M291.70M330.86M369.13M323.23M
EBITDA Margin22.16%24.05%23.44%22.67%24.24%18.24%17.42%14.87%16.34%21.79%21.73%21.83%25.45%24.60%19.71%
Net Income35.03M47.70M48.64M48.62M51.88M36.61M42.39M41.15M61.68M115.62M155.91M184.63M206.63M227.40M262.49M
Net Income Margin15.89%17.01%15.96%15.09%16.64%11.52%10.50%7.74%8.55%12.30%13.39%13.82%15.89%15.16%16.00%
R&D-8.80M10.17M5.92M4.59M6.01M7.62M8.98M15.26M29.49M42.15M40.85M51.07M63.98M75.28M
R&D as % of Total Revenue-3.14%3.34%1.84%1.47%1.89%1.89%1.69%2.12%3.14%3.62%3.06%3.93%4.26%4.59%
Interest Expense4.44M3.29M4.04M4.80M1.52M51.58K120.90K1.97M6.49M1.69M2.67M3.61M5.32M3.96M1.82M
Interest Expense % of Total Revenue2.01%1.17%1.33%1.49%0.49%0.02%0.03%0.37%0.90%0.18%0.23%0.27%0.41%0.26%0.11%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets199.96M267.12M329.71M381.37M592.28M625.26M670.54M827.43M1.15B1.24B1.41B1.79B2.03B2.22B2.43B
Total Liabilities77.54M108.15M122.10M131.10M60.40M72.65M88.73M217.11M427.68M399.52M427.24M631.13M696.84M814.06M875.32M
Total Equity122.42M158.96M207.61M250.27M531.87M552.62M579.13M606.08M669.15M785.20M905.51M1.08B1.25B1.32B1.46B
Cash26.09M39.12M20.03M29.58M174.64M71.73M87.49M82.40M110.90M98.26M250.80M320.33M221.29M289.85M431.47M
Total Debt44.28M69.18M73.50M73.00M---82.42M132.63M112.75M42.05M129.08M202.01M197.87M-
Net Debt18.19M30.06M53.47M43.42M-174.64M-71.73M-87.49M18.66K21.73M14.48M-208.75M-191.25M-19.27M-91.97M-

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow34.43M41.26M30.01M68.29M62.88M61.30M62.26M58.89M167.36M272.90M329.72M402.18M346.15M389.59M460.60M
Investing Cash Flow-38.79M-45.26M-51.26M-47.32M-75.58M-148.34M-34.15M-152.88M-173.14M-235.04M-63.70M-375.65M-425.77M-186.40M-
Financing Cash Flow19.52M17.01M2.17M-11.42M157.76M-15.87M-13.17M88.90M28.67M-50.94M-134.32M35.43M-9.18M-123.59M-
Capital Expenditure36.75M45.26M51.29M47.36M67.03M111.67M89.11M132.43M123.05M98.13M174.80M210.55M287.47M217.54M241.87M
Free Cash Flow-2.32M-3.99M-21.28M20.93M-4.15M-50.37M-26.85M-73.55M44.31M174.76M154.91M191.62M52.34M172.05M218.73M
Dividends Paid4.20M9.12M3.97M10.69M1.57M15.87M15.87M17.60M16.33M26.27M52.54M59.10M59.61M131.99M163.29M
FCF to OCF-6.73%-9.67%-70.93%30.65%-6.60%-82.16%-43.12%-124.90%26.48%64.04%46.98%47.65%15.12%44.16%47.49%
Dividend Paid to FCF-181.06%-228.62%-18.65%51.07%-37.71%-31.51%-59.11%-23.93%36.86%15.03%33.91%30.84%113.89%76.72%74.65%

Earnings

Report DateAug 6, 2015Oct 22, 2015Feb 24, 2016Apr 22, 2016Aug 27, 2016Oct 27, 2016Feb 25, 2017Apr 25, 2017Aug 25, 2017Oct 25, 2017Mar 16, 2018Apr 26, 2018Aug 24, 2018Oct 24, 2018Mar 15, 2019Apr 27, 2019Aug 31, 2019Oct 23, 2019Mar 28, 2020Apr 23, 2020Aug 21, 2020Oct 18, 2020Feb 26, 2021Apr 20, 2021Jul 21, 2021Oct 15, 2021Mar 16, 2022Apr 19, 2022Jul 27, 2022Oct 19, 2022Mar 22, 2023Apr 26, 2023Aug 4, 2023Oct 20, 2023Mar 22, 2024Apr 16, 2024Jun 30, 2024Oct 14, 2024Mar 26, 2025Apr 16, 2025Jun 30, 2025
EPS Estimate-----------------------------------------
EPS Actual0.040.030.040.020.030.030.010.020.040.030.030.020.030.030.030.010.030.060.070.030.080.100.120.130.090.110.110.120.140.100.100.090.090.100.130.100.100.120.110.100.12
Surprise-----------------------------------------
TimingAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-market-Pre-marketPre-marketAfter-hours-

Key Statistics & Ratios

Market Cap4.72B
Enterprise Value4.46B
Trailing P/E16.76
Forward P/E0.00
Price / Sales2.75
Price / Book3.17
EPS0.54
Book Value2.86
Revenue (TTM)1.72B
Gross Profit (TTM)621.99M
EBITDA434.47M
Profit Margin16.43%
Operating Margin16.23%
Return on Equity20.54%
Return on Assets8.23%
Shares Outstanding522.08M
Shares Float296.23M
Beta0.10
Dividend Yield3.32%
Dividend Rate0.30
Payout Ratio55.10%

Dividends

20261×
0.20May 28, 2026
20252×
0.10Sep 10, 20250.20May 12, 2025
20242×
0.10Sep 9, 20240.15Apr 25, 2024
20231×
0.15Apr 24, 2023
20221×
0.11Apr 29, 2022
20211×
0.10Apr 29, 2021
20201×
0.05May 13, 2020
20191×
0.05May 6, 2019
20181×
0.03Jun 4, 2018
20171×
0.03Apr 27, 2017
20161×
0.03Apr 1, 2016

Stock Splits

  • Apr 24, 20231.32:1
  • Apr 29, 20211.5525:1
  • May 6, 20191.6:1
  • Apr 1, 201620:10